A novel evolutionarily conserved element is a general transcriptional repressor of p21WAF1/CIP1

Cancer Research

Volumn 72, Issue 23, 2012, Pages 6236-6246

  Xu, Weiguo ^a   Zhu, Qi ^a   Wu, Zhenghua ^a   Guo, Hao ^a   Wu, Fengjuan ^a   Mashausi, Dhahiri S ^a   Zheng, Chengjie ^b   Li, Dawei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYTARABINE; DOXORUBICIN; FLUOROURACIL; HYDROXYUREA; OXALIPLATIN; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; FEMALE; GENETIC CONSERVATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY SEQUENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BINDING SITES; CELL LINE, TUMOR; CONSERVED SEQUENCE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EPIGENETIC REPRESSION; FEMALE; HUMANS; INVERTED REPEAT SEQUENCES; MICE; MICE, INBRED BALB C; MICE, NUDE; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; TRANSFECTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84870356227     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-1236     Document Type: Article

References (39)

1. Martin-Caballero J, Flores JM, Garcia-Palencia P, Serrano M. Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. Cancer Res 2001;61:6234-8.
2. Topley GI, Okuyama R, Gonzales JG, Conti C, Dotto GP. p21(WAF1/Cip1) functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. Proc Natl Acad Sci U S A 1999;96:9089-94. (Pubitemid 29374712)
3. Poole AJ, Heap D, Carroll RE, Tyner AL. Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon. Oncogene 2004;23:8128-34. (Pubitemid 39531853)
4. Wei J, Zhao J, Long M, Han Y, Wang X, Lin F, et al. p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell. BMC Cancer 2010;10:632.
5. Abukhdeir AM, Vitolo MI, Argani P, De Marzo AM, Karakas B, Konishi H, et al. Tamoxifen-stimulated growth of breast cancer due to p21 loss. Proc Natl Acad Sci U S A 2008;105:288-93.
6. Plentz RR, Park YN, Lechel A, Kim H, Nellessen F, Langkopf BH, et al. Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis. Hepatology 2007;45:968-76. (Pubitemid 46631565)
7. Matsui TA, Sowa Y, Murata H, Takagi K, Nakanishi R, Aoki S, et al. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line. Int J Oncol 2007;31:915-22.
8. Hata T, Yamamoto H, Ngan CY, Koi M, Takagi A, Damdinsuren B, et al. Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells. Mol Cancer Ther 2005;4:1585-94. (Pubitemid 41556442)
9. Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 2005;65:3980-5. (Pubitemid 40775632)
10. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009;9:400-14.
11. Lane DP, Cheok CF, Brown C, Madhumalar A, Ghadessy FJ, Verma C. Mdm2 and p53 are highly conserved from placozoans to man. Cell Cycle 2010;9:540-7.
12. Rossi M, Demidov ON, Anderson CW, Appella E, Mazur SJ. Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites. Nucleic Acids Res 2008;36:7168-80.
13. Gartel AL, Tyner AL. Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res 1999;246:280-9. (Pubitemid 29393989)
14. Nobrega MA, Ovcharenko I, Afzal V, Rubin EM. Scanning human gene deserts for long-range enhancers. Science 2003;302:413. (Pubitemid 37296259)
15. Drake JA, Bird C, Nemesh J, Thomas DJ, Newton-Cheh C, Reymond A, et al. Conserved noncoding sequences are selectively constrained and not mutation cold spots. Nat Genet 2006;38:223-7. (Pubitemid 43177238)
16. Woolfe A, Goodson M, Goode DK, Snell P, McEwen GK, Vavouri T, et al. Highly conserved non-coding sequences are associated with vertebrate development. PLoS Biol 2005;3:e7.
17. Birney E, Stamatoyannopoulos JA, Dutta A, Guigo R, Gingeras TR, Margulies EH, et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007;447:799-816.
18. Cameron RA, Chow SH, Berney K, Chiu TY, Yuan QA, Kramer A, et al. An evolutionary constraint: strongly disfavored class of change in DNA sequence during divergence of cis-regulatory modules. Proc Natl Acad Sci U S A 2005;102:11769-74. (Pubitemid 41170800)
19. Wolf JB. Genetic architecture and evolutionary constraint when the environment contains genes. Proc Natl Acad Sci U S A 2003;100:4655-60. (Pubitemid 36457785)
20. Lindblad-Toh K, Garber M, Zuk O, Lin MF, Parker BJ, Washietl S, et al. A high-resolution map of human evolutionary constraint using 29 mammals. Nature 2011;478:476-82.
21. Jeong Y, Oh S. Identification of an evolutionarily conserved, functional noncoding element regulated by Six1 homeoprotein. Genes Genet Syst 2010;85:233-40.
22. Feng W, Huang J, Zhang J, Williams T. Identification and analysis of a conserved Tcfap2a intronic enhancer element required for expression in facial and limb bud mesenchyme. Mol Cell Biol 2008;28:315-25.
23. Li D, Tian Y, Ma Y, Benjamin T. p150(Sal2) is a p53-independent regulator of p21(WAF1/CIP). Mol Cell Biol 2004;24:3885-93.
24. Jung YS, Qian Y, Chen X. Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal 2010;22:1003-12.
25. Nakano K, Mizuno T, Sowa Y, Orita T, Yoshino T, Okuyama Y, et al. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J Biol Chem 1997;272:22199-206. (Pubitemid 27382850)
26. Sowa Y, Orita T, Hiranabe-Minamikawa S, Nakano K, Mizuno T, Nomura H, et al. Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites. Ann N Y Acad Sci 1999;886:195-9. (Pubitemid 30042437)
27. Sowa Y, Orita T, Minamikawa S, Nakano K, Mizuno T, Nomura H, et al. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem Biophys Res Commun 1997;241:142-50. (Pubitemid 28033553)
28. Hantusch B, Kalt R, Krieger S, Puri C, Kerjaschki D. Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cells. BMC Mol Biol 2007;8:20.
29. Wang CH, Tsao YP, Chen HJ, Chen HL, Wang HW, Chen SL. Transcriptional repression of p21((Waf1/Cip1/Sdi1)) gene by c-jun through Sp1 site. Biochem Biophys Res Commun 2000;270:303-10. (Pubitemid 30440432)
30. Thomas DJ, Rosenbloom KR, Clawson H, Hinrichs AS, Trumbower H, Raney BJ, et al. The ENCODE Project at UC Santa Cruz. Nucleic Acids Res 2007;35:D663-7. (Pubitemid 46056288)
31. Guigo R, Flicek P, Abril JF, Reymond A, Lagarde J, Denoeud F, et al. EGASP: the human ENCODE Genome Annotation Assessment Project. Genome Biol 2006;7 Suppl 1:S2.1-31.
32. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 2004;306:636-40.
33. Tan NY, Khachigian LM. Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol 2009;29:2483-8.
34. Iwahori S, Yasui Y, Kudoh A, Sato Y, Nakayama S, Murata T, et al. Identification of phosphorylation sites on transcription factor Sp1 in response to DNA damage and its accumulation at damaged sites. Cell Signal 2008;20:1795-803.
35. Zhang Y, Dufau ML. Repression of the luteinizing hormone receptor gene promoter by cross talk among EAR3/COUP-TFI, Sp1/Sp3, and TFIIB. Mol Cell Biol 2003;23:6958-72. (Pubitemid 37214663)
36. Song J, Ugai H, Kanazawa I, Sun K, Yokoyama KK. Independent repression of a GC-rich housekeeping gene by Sp1 and MAZ involves the same cis-elements. J Biol Chem 2001;276:19897-904.
37. Zhao S, Venkatasubbarao K, Li S, Freeman JW. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. Cancer Res 2003;63:2624-30. (Pubitemid 36605205)
38. Myers RM, Stamatoyannopoulos J, Snyder M, Dunham I, Hardison RC, Bernstein BE, et al.Auser's guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol 2011;9:e1001046.
39. Collins JF, Hu Z. Promoter analysis of intestinal genes induced during iron-deprivation reveals enrichment of conserved SP1-like binding sites. BMC Genomics 2007;8:420.